A carregar...
Use of anti-TNF drug levels to optimise patient management
Anti-tumour necrosis factor (TNF) therapies, such as infliximab, adalimumab, certolizumab pegol and golimumab, have been proven to be effective for the treatment of patients with Crohn's disease and ulcerative colitis. However, 10%–30% of patients with inflammatory bowel disease (IBD) show no i...
Na minha lista:
| Publicado no: | Frontline Gastroenterol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5369499/ https://ncbi.nlm.nih.gov/pubmed/28839870 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/flgastro-2016-100685 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|